Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase 1 4 Phase 1/2 2 Phase NA 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

NETWORK 5 OTHER 3 NIH 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 437 Breast Neoplasms 382 Neoplasms 290 Prostatic Neoplasms 192 Neoplasm Metastasis 154 Multiple Myeloma 147 Colorectal Neoplasms 123 Lung Neoplasms 104 Ovarian Neoplasms 102 Parkinson Disease 4, Autosomal Dominant Lewy Body 98 Melanoma 95 Lymphoma, Follicular 94 Recurrence 88 Lymphoma, Non-Hodgkin 82 Papillomavirus Infections 81 Leukemia, Lymphocytic, Chronic, B-Cell 81 Carcinoma, Hepatocellular 80 Stomach Neoplasms 76 Small Cell Lung Carcinoma 72 Leukemia, Myeloid, Acute 70 Pancreatic Neoplasms 66 Pain 66 Uterine Cervical Neoplasms 64 Carcinoma, Renal Cell 64 Keratosis, Actinic 63 Urinary Bladder Neoplasms 59 Lymphoma, Large B-Cell, Diffuse 53 Myasthenia Gravis 52 Leiomyoma 49 Carcinoma 49

Interventions

pazopanib 1 carotuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × INDUSTRY × Hemangiosarcoma × Clear all

NCT02979899 2020-05-12

TAPPAS

Tracon Pharmaceuticals Inc.

Phase 3 Completed

128 enrolled 13 charts

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡